Loading...
Patient Taking A Novel Oral Anticoagulant Presents With Major GI Bleeding
Novel Oral Anticoagulants (NOACs) such as Dabigatran, Rivaroxaban, Apixaban and Edoxaban are becoming increasingly popular choices for anticoagulation in place of oral Vitamin K Antagonists in various clinical settings. However, they are thought to be associated with an increased risk of gastrointes...
Na minha lista:
| Udgivet i: | J Atr Fibrillation |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Cardiofront, Inc
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4955887/ https://ncbi.nlm.nih.gov/pubmed/27957203 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4022/jafib.1218 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|